Bromperidol

DB12401ApprovedWithdrawnSmall molecule

Bromperidol is a first-generation butyrophenone antipsychotic used in the treatment of schizophrenia and other psychotic manifestations. Bromperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.

Chemical structure of Bromperidol
Mechanism
Curator reviewed
Formula / weight
C21H23BrFNO2 · 420.322 g/mol (avg)
Code names
R-11333

Resolves to

Compound
UNIILYH6F7I22ECAS10457-90-6ChEMBLCHEMBL28218ChEBI31305PubChem2448
Clinical / RWD
RxNorm19777ATCN05AD06
Structure
InChIKeyRKLNONIVDFXQRX-UHFFFAOYSA-NSMILESOC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1
Targets
P14416DRD2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
718Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
7ContraindicationsEach with its own population and attribute set
Sign in
8Marketed productsAcross 3 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bromperidol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In